Rodman & Renshaw Initiates Coverage On Coya Therapeutics With Buy Rating, Announces Price Target of $18
Rodman & Renshaw Initiates Coverage On Coya Therapeutics With Buy Rating, Announces Price Target of $18
羅德曼公司開始對Coya Therapeutics進行買入評級，並宣佈目標價格爲18美元。
Rodman & Renshaw analyst Elemer Piros initiates coverage on Coya Therapeutics (NASDAQ:COYA) with a Buy rating and announces Price Target of $18.
Rodman & Renshaw分析師Elmer Piros開始對Coya Therapeutics (NASDAQ:COYA)進行覆蓋，並給予買入評級並宣佈18美元的目標價。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。